• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.03% Nasdaq Up 0.29%

    More On CYP.AX

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    Cynata Therapeutics Limited (CYP.AX)

    -ASX
    0.37 Up 0.02(4.29%) Jan 26
    Add to Portfolio
    Prev Close:0.35
    Open:0.35
    Bid:0.36
    Ask:0.39
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:0.35 - 0.37
    52wk Range:0.28 - 0.55
    Volume:20,000
    Avg Vol (3m):27,296
    Market Cap:20.06M
    P/E (ttm):N/A
    EPS (ttm):-0.07
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in AUD.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Cynata Therapeutics Limited, through its subsidiary, Cynata Incorporated, develops a therapeutic stem cell platform in Australia. It focuses on the development and commercialization of the Cymerus, a mesenchymal stem cell technology for human ther... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback